Skip to main content

Advertisement

Log in

Influence of Fuzheng Huayu Tablet (扶正化瘀片) on mental state and social function of patients with post-hepatitis B liver cirrhosis

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To observe the influence of Fuzheng Huayu Tablet (扶正化瘀片, FZHYT) on mental state and social activity of patients with post-hepatitis B liver cirrhosis (LC-HB).

Methods

Adopting grouped randomized double-blinded control method, 180 LC-HB patients in 3 research centers were distributed to 2 groups, the treated group and the control group, 90 in each group. Patients in the treated group were administered with FZHYT; while those in the control group treated with conventional therapy combined with placebo, the course for all patients were 6 months. Their mental state and social activity were evaluated before treatment, after 3 months’ treatment and at terminal of the 6-month therapeutic course by estimating with Zung self-rating anxiety scale (SAS), self-rating depression scale (SDS) and social deficit screening scale (SDSS). Additionally, the basic demographic materials, liver function, cirrhosis index, hepatic and splenic images, blood coagulation function, etc. in the patients were tested and compared as well.

Results

As compared with before treatment, the normal rate of SAS and SDS scores increased and the social deficit rate decreased in the treated group significantly after treatment, showing statistical significance (P<0.05 or P<0.01); while in the control group, change was only shown in the social deficit (P<0.01), inter-group comparisons after treatment showed significant differences in all the three indexes (P<0.05 or P<0.01). Additionally, after treatment, levels of liver function, cirrhosis, blood coagulation function and splenomegaly in the treated group were all improved significantly P<0.05 or P<0.01), and the improvements were better than those in the control group (P<0.01) in levels of total bilirubin (TBIL), albumin (ALB), type IV collagen (IV-C), prothrombin time (PT), prothrombin activity (PTA).

Conclusion

Most patients of LC-HB have mental disturbance and social activity deficit, which could definitely be improved by intervention with Chinese FZHYT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lu ZY, Zhong NS. Internal medicine science (7th ed). Beijing: People’s Medical Publishing House; 2008:453–454.

    Google Scholar 

  2. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Lédinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009;29:242–249.

    Article  PubMed  Google Scholar 

  3. Li WY, Jiang YF, Jin QL Zhang H, Feng XW, Niu JQ. Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection. J Biomed Biotechnol 2010;14:138–145.

    Google Scholar 

  4. Anna S, Brian J. Chronic hepatitis B. Hepatology 2007;45:507–538.

    Article  Google Scholar 

  5. Jordi B, Morris S, Josep M. Clinical management of hepatocellular carcinoma.conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421–430.

    Article  Google Scholar 

  6. Yang HZ, Wang FL, Wang YZ, Shen WS, Xu GL, Yang YW, et al. The clinical study on chronic hepatitis B treated by the four-step therapeutics of traditional Chinese medicine. J Chin Med Mat (Chin) 2006;29:748–752.

    Google Scholar 

  7. Shi WQ, Ru QJ, Cai GY. Effect of umbilical sticking therapy with Qi Tou Xiao Gu plaster in treating liver cirrhosis patients with portal hypertension. Chin J Integr Tradit West Med (Chin) 2008;28:642–647.

    Google Scholar 

  8. Den X, Liang J, Wu FS, Li YB, Tang YF. Influence of traditional Chinese medicine therapy on quality of life of patients with posthepatitic cirrhosis. Lishizhen Med Mater Med Res (Chin) 2010;21:3314–3316.

    Google Scholar 

  9. Liang J, Den X, Yu L, Wu FS, Li X, An YH. Study on the establishment of the evaluation index system of Chinese medicine treatment of hepatitis cirrhosis. Liaoning J Tradit Chin Med (Chin) 2009;6:2017–2019.

    Google Scholar 

  10. Digestive System Disease Committee of Chinese Association of integrative Medicine. Cirrhosis of combining traditional Chinese and western medicine treatment scheme (draft). Chin J Integr Tradit West Med (Chin) 2004;24:869–871.

    Google Scholar 

  11. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397–417.

    Article  Google Scholar 

  12. Santini MT, Rainaldi G, Indovina PL. Multicelluar tumour spheroids in radiation biology. Int J Radiat Biol 1999;75:787–789.

    Article  PubMed  CAS  Google Scholar 

  13. Zhang MY. Manual of rating scales for psychiatry. Changsha: Hunan Science and Technology Press; 1993:162–164.

  14. Tan CY, Liu P. Theoretical origin of pathogenesis on accumulation due to deficiency of liver cirrhosis and clinical significance. Acta Univ Tradit Med Sin Pharmacol Shanghai (Chin) 2010;24(4):25–28.

    Google Scholar 

  15. Zhang Q, Liu P, Zhang HW, Wang L, Dou GL, Chen HF, et al. Study on the patterns of TCM syndrome differentiation of 900 patients with posthepatitic cirrhosis. Chin J Integr Tradit West Med (Chin) 2006;26:694–697.

    Google Scholar 

  16. Yuan Z. Clinical applicative characteristics of biopsychosocial medical mode. Chin J Clin Rehabilit (Chin) 2005;9:252–253.

    Google Scholar 

  17. Kim SH, Oh EG, Lee WH. Symptom exper ience, psychological distress, and quality of life in Korean patients with liver cirrhosis: a cross-sectional survey. Int J Nurs Stud 2006;43:1047–1056.

    Article  PubMed  Google Scholar 

  18. Tang JS, Xu CM, Zhai J, Zhao GF, Li CQ, Liang YR. A study on the relationship of social disability to subjective support and the degree of condition in patients with anxiety. Chin J Clin Rehabilit (Chin) 2003;7:2568–2569.

    Google Scholar 

  19. Zandi M, Adib-Hajbagheri M, Memarian R, Nejhad AK, Alavian SM. Effects of a self-care program on quality of life of cirrhotic patients referring to Tehran Hepatitis Center. Health Qual Life Outcomes 2005;18;3:35.

    Article  Google Scholar 

  20. Luk JM, Wang X, Liu P, Wong KF, Chan KL, Tong Y, et al. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer:from laboratory discovery to clinical evaluation. Liver Int 2007;27:879–890.

    Article  PubMed  CAS  Google Scholar 

  21. Li YM, Yang HZ, Guan WB, Ke QS, Dai M, Xie HP, et al. Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients. World J Gastroenterol 2008;14:6060–6063.

    Article  PubMed  Google Scholar 

  22. Huang J, Huang H, Jiao Y, Ai G, Huang T, Li L, et al. Effect of anluohuaxian tablet combined with gamma-IFN on schistosomal liver fibrosis. J Huazhong Univ Sci Technol Med Sci (Chin) 2009;29:53–61.

    Article  CAS  Google Scholar 

  23. Tong GD, Zhou DQ, He JS, Zhang L, Chen ZF, Xiao CL, et al. Clinical research on navel application of Shehuang Paste combined with Chinese herbal colon dialysis in treatment of refractory cirrhotic ascites complicated with azotemia. World J Gastroenterol 2006;12:7798–7804.

    PubMed  Google Scholar 

  24. Liang J, Qin LK, Den X, Wu FS, Li X, An YH. Systematic review of therapeutic effects of traditional Chinese medicine on posthepatitic cirrhosis at early stage. Acta Univ Tradit Med Sin Pharmacol Shanghai (Chin) 2009;23:20–23.

    Google Scholar 

  25. Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther 2009;30:469–476.

    Article  PubMed  CAS  Google Scholar 

  26. Jin S, Yan L, Li B, Wen T, Zhao J, Zeng Y, et al. Quality of life and psychologic distress of recipients after adult livingdonor liver transplantation (LDLT)-A study from mainland China. Transplant Proc 2010;42:2611–2616.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian Liang  (梁 健).

Additional information

Supported by Project of Guangxi Science and Technology Department (No. 2010 GXNSFA 013217), Key Project of Guangxi Health Department (No. 2010095) and Guangxi Provincial Fund of Natural Science (No. Gui Ke Zi 0832174)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deng, X., Liang, J., Wu, Fs. et al. Influence of Fuzheng Huayu Tablet (扶正化瘀片) on mental state and social function of patients with post-hepatitis B liver cirrhosis. Chin. J. Integr. Med. 18, 466–472 (2012). https://doi.org/10.1007/s11655-012-1112-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-012-1112-0

Keywords

Navigation